Gerhard Held

Title: Gerhard Held: Innovator in Cancer Treatment

Introduction

Gerhard Held is a notable inventor based in Homburg, Germany. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on developing binding molecules that target specific cancer cells, showcasing his commitment to advancing medical science.

Latest Patents

Gerhard Held holds a patent for "Methods and composition for a binding molecule targeting cancer cells expressing SSX2 peptide 41-49 in HLA-A*0201 context." This patent discloses Synovial Sarcoma X breakpoint 2 binding molecules and methods for their use in the detection and treatment of cancer. His innovative approach aims to improve the accuracy and effectiveness of cancer therapies.

Career Highlights

Throughout his career, Gerhard Held has worked with prestigious institutions such as Children's National Medical Center and Washington University. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Gerhard has collaborated with notable professionals, including Eric Yvon and Catherine M. Bollard. These partnerships have enhanced his research and expanded the impact of his work in cancer treatment.

Conclusion

Gerhard Held's contributions to cancer research through his innovative patents and collaborations highlight his dedication to improving patient outcomes. His work continues to inspire advancements in medical science and cancer treatment.